Related Experiment Video
Updated: Aug 15, 2026

Angiogenesis in the Ischemic Rat Lung
Published on: February 8, 2013
Development of microscopic polyangiitis in patients with chronic airway disease
K Takahashi1, S Hayashi, O Ushiyama
1Department of Medicine, Saga University Medical School, Nabeshima 5-1-1, Saga 849-8501, Japan. hayashs@cc.saga-u.ac.jp
Abstract:
Microscopic polyangiitis (MPA) is a rare systemic vasculitis syndrome, which is often accompanied by positive myeloperoxidase-specific antineutrophil cytoplasmic antibody (MPO-ANCA). While pulmonary involvement of MPA consists mainly of diffuse alveolar hemorrhage and interstitial pneumonia, bronchiectasis has been reported as a pulmonary lesion in association with MPA. To investigate the clinical features of patients with MPA, focusing on the presence or the absence of preceding chronic airway diseases (CAD), we conducted a retrospective observational study of 26 patients in the last 13 years at Saga University Hospital. The clinical records and radiologic chest examinations were reviewed retrospectively. Pulmonary manifestations were alveolar hemorrhage in 3 patients (12%) and interstitial pneumonia in 5 (19%). Bronchiectasis, defined by the findings of chest radiograph and computed tomography, was found in 9 patients (35%). Four patients (15%) with bronchiectasis and one patient (4%) with chronic bronchitis had experienced chronic bronchial suppuration prior to the onset of MPA. Ten patients were classified as having chronic airway disease (CAD) before the onset of MPA. MPO-ANCA tended to be lower in the CAD group than in the non-CAD group. None of the patients in the CAD group had pulmonary hemorrhage or interstitial pneumonia. Only one patient (10%) in the CAD group died within 90 days of the onset of MPA, while 7 (43.8%) of the non-CAD group died. Our study suggests that MPA may result in part from CAD and that the clinical course of MPA with CAD may be different from MPA without CAD.
Insights
Microscopic polyangiitis (MPA) with preceding chronic airway disease (CAD) presents differently and has a better survival rate. This suggests CAD may influence MPA development and clinical course.
Area of Science:
- Rheumatology
- Pulmonology
- Internal Medicine
Background:
- Microscopic polyangiitis (MPA) is a rare systemic vasculitis often associated with myeloperoxidase-specific antineutrophil cytoplasmic antibodies (MPO-ANCA).
- Pulmonary manifestations typically include diffuse alveolar hemorrhage and interstitial pneumonia, but bronchiectasis has also been observed.
Purpose of the Study:
- To investigate the clinical features of MPA patients, specifically comparing those with and without pre-existing chronic airway diseases (CAD).
Main Methods:
- A retrospective observational study of 26 MPA patients over 13 years at Saga University Hospital.
- Review of clinical records and radiological chest examinations (chest radiograph and CT).
Main Results:
- Bronchiectasis was present in 35% of patients; 15% with bronchiectasis and 4% with chronic bronchitis had prior chronic bronchial suppuration.
- 10 patients (38%) had pre-existing CAD. The CAD group had lower MPO-ANCA levels, no pulmonary hemorrhage or interstitial pneumonia, and significantly better 90-day survival (10% vs. 43.8%).
Conclusions:
- Chronic airway disease may contribute to the development of MPA.
- MPA in patients with CAD exhibits distinct clinical features and a more favorable prognosis compared to MPA without CAD.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Peripheral Artery Disease I: Introduction
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

